North America Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

North America Contraceptives Market is segmented by Product (Drugs, Devices, and Gender), and Geography. The market provides the value (in USD million) for the above-mentioned segments.

North America Contraceptives Market Size

Single User License


Team License


Corporate License


Book before:
North America Contraceptives Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.90 %

Major Players

North America Contraceptives Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

North America Contraceptives Market Analysis

The number of unwanted pregnancies is found increasing in the North American region, and it is a matter of serious concern all around the world. The increase in unwanted pregnancies has thus increased the usage of contraceptive devices in North America. Thus all these factors have been primary drivers for the growth of this market.

Moreover, initiatives by the government to raise awareness regarding contraceptives and family planning have also helped the growth of the market. As the right to obtain and use contraceptives is part of the fundamental right to privacy guaranteed by the United States Constitution. Thus, government initiatives are promoting the use of contraceptives to avoid unnecessary births. However, the side effects of contraceptive devices have been restraining market growth.

North America Contraceptives Market Trends

This section covers the major market trends shaping the North America Contraceptives Market according to our research experts:

Condoms are Expected to Dominate the Contraceptive Devices Market

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). With its proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS. They also, to a lesser extent, protect against genital herpes, human papillomavirus (HPV), and syphilis.

The prevalence of STIs, though decreasing, but is still high in some parts of North America. As a result, the use of condoms has been increasing in developing economies like Mexico and developed countries like the United States.

According to a 2017 report from the U.S. Centers for Disease Control and Prevention, about one-third of the men said they were used to using a condom every time they had sex. This number was reported to have increased in the past decade as per the report. Therefore, the increased use of condoms is expected to help the market growth.

North America Contraceptives Market - Prevalnce of Chlamdiya in some States of The United States of America, per 100,000 Population

North America Contraceptives Industry Overview

United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

North America Contraceptives Market Leaders

  1. Bayer AG

  2. Merck & Co. Inc.

  3. Teva Pharmaceuticals Ltd

  4. Pfizer

  5. Agile Therapeutics

*Disclaimer: Major Players sorted in no particular order

North America Contraceptives Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

North America Contraceptives Market Report - Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Rate of Unintended Pregnancies

      2. 4.2.2 Rise in Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Products

      1. 5.1.1 By Drugs

        1. Oral Contraceptives

        2. Topical Contraceptives

        3. Contraceptive Injectable

      2. 5.1.2 By Device

        1. Condoms

        2. Diaphragms

        3. Cervical Caps

        4. Sponges

        5. Vaginal Rings

        6. IUDs

        7. Other Devices

    2. 5.2 By Gender

      1. 5.2.1 Male

      2. 5.2.2 Female

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico


    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Pfizer Inc.

      3. 6.1.3 Merck & Co. Inc.

      4. 6.1.4 Teva Pharmaceuticals Ltd

      5. 6.1.5 Agile Therapeutics

      6. 6.1.6 Allergan PLC

      7. 6.1.7 Ani Pharmaceuticals Inc.

      8. 6.1.8 Church & Dwight Co. Inc.

      9. 6.1.9 Fuji Latex Co. Ltd

      10. 6.1.10 Johnson & Johnson Ltd

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Contraceptives Industry Segmentation

As per the scope of the report, contraceptive drugs and devices are used for birth control. Contraception is more commonly known as fertility, and birth control is described as the method used to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. The proper use of contraceptives, such as female and male condoms, also prevents the spread of sexually transmitted diseases.

By Products
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Cervical Caps
Vaginal Rings
Other Devices
By Gender
North America
United States
Need A Different Region Or Segment?
Customize Now

North America Contraceptives Market Research FAQs

The North America Contraceptives Market is projected to register a CAGR of 5.90% during the forecast period (2024-2029)

Bayer AG, Merck & Co. Inc., Teva Pharmaceuticals Ltd, Pfizer and Agile Therapeutics are the major companies operating in the North America Contraceptives Market.

The report covers the North America Contraceptives Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Contraceptives Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

North America Contraceptives Industry Report

Statistics for the 2024 North America Contraceptives market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Contraceptives analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

North America Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)